Skip to main content
NIH funding notice PAS-19-210

Progression Markers for Cognitive Impairment in Parkinson's Disease Dementia (R01 Clinical Trial Not Allowed)

Closed on November 5, 2019.

Posted
March 5, 2019
Close date
November 5, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,155,000 in first-year total cost, median $1,155,000.

Most frequent study sections

  1. Clinical Neuroscience and Neurodegeneration Study Section[CNN]1

Most frequent institutions

  1. UNIVERSITY OF ROCHESTER1
Competing awards under PAS-19-210 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Comprehensive Multivariable Deep Learning Models to Identify Predictors of Cognitive Change in PD1RF1NS115141-01A1VENUTO, CHARLES STANLEYUNIVERSITY OF ROCHESTER, NY$1,155,000CNN

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.